Plain-English translation of NCT06770010 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a program called Cogmed+ — a home-based digital training program that helps improve working memory (the ability to hold and use information briefly). The program combines memory exercises on a tablet with social support, like group kickoff events and peer support. It's designed for children and teens with sickle cell disease who struggle with memory and thinking problems.
Sickle cell disease can affect how the brain works and cause thinking and memory problems, even when there are no visible signs of stroke. Very few treatments exist for these cognitive challenges, so researchers developed this program to see if the medication can help children improve their memory and whether adding social support makes them more likely to stick with the training.
You likely qualify if…
You likely don't qualify if…
First, you'll complete a brief thinking and memory screening test. If your working memory is weaker than expected, you'll move into the main program where you'll use the Cogmed+ training on a tablet at home. You'll also take part in social support activities like group kickoff events and work with a peer navigator. The program teaches memory strategies while you practice memory exercises over several weeks.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States